Century Therapeutics, Inc.IPSCNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank17
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P17
Within normal range
vs 3Y Ago
-7.4x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$-103.88M+5.7%
2024$-110.14M-24.7%
2023$-88.35M-728.7%
2022$14.05M+115.8%
2021$-89.00M-115.7%
2020$-41.27M-155.3%
2019$-16.17M-